Your session is about to expire
← Back to Search
Device
Digital Health Feedback System for HIV Prevention
N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial will use new technology to study how well people adhere to their HIV prevention medication.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Medication Taking Adherence
The system positive detection accuracy (PDA) will be derived
Secondary outcome measures
Determine the percentage of participants starting or continuing HIV PrEP who find the DHFS acceptable and easy to use.
Trial Design
1Treatment groups
Experimental Treatment
Group I: DHFS with IS-TruvadaExperimental Treatment1 Intervention
Digital Health Feedback System (DHFS) with IS-Truvada 1 capsule daily for 12 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Digital Health Feedback System
2013
Completed Phase 4
~120
Find a Location
Who is running the clinical trial?
Proteus Digital Health, Inc.Industry Sponsor
10 Previous Clinical Trials
1,274 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,121 Previous Clinical Trials
1,520,824 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,667 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research currently accepting participants?
"According to clinicaltrials.gov, this research program is no longer recruiting patients. The study was published on December 1st 2016 and its most recent edit took place August 23rd 2021. Notwithstanding, 24 other trials are still enrolling participants at the time of this writing."
Answered by AI
Share this study with friends
Copy Link
Messenger